Health and Safety

2,180 petitions

Update posted 12 hours ago

Petition to Johnson & Johnson

Demand Johnson & Johnson add an ovarian cancer warning label to talcum powder products

The Issue More than 40 years ago, scientists identified a link between talcum powder and ovarian cancer. Despite these findings, Johnson & Johnson continues to deny a harrowing fact: the risk of developing ovarian cancer. Specifically advertised for women to apply to their genital region and onto their babies, the company’s family-friendly ads aim to obliterate any accusation that their product is unsafe. In fact, one of their better-known slogans describes the products as “the kindest powder in the world.” The truth, however, is not so kind. Currently, Johnson & Johnson faces more than 11,700 claims that its baby powder causes cancer. Following media reports of internal documents indicating company knowledge of the dangers of their powder, thousands of plaintiffs now accuse J&J of hiding the cancer risk to protect their business. The Data In 1971, The Journal of Obstetrics and Gynaecology of the British Commonwealth published research that found talcum particles “deeply embedded” in 10 of 13 ovarian tumors. In 1982, the link between talcum powder use and ovarian cancer was statistically proven and published as fact in the medical journal, Cancer. Since then, multiple studies have identified a connection between talcum powder and ovarian cancer. The research has emerged from organizations and publications like Obstetrics & Gynecology, The National Toxicology Program, Jersey Journal, American Journal of Epidemiology and Health Canada. Since 1994, the Cancer Prevention Coalition has requested consumer labels warning users about the link between talc and cancer. No warning labels were granted. As recently as this year, Reproductive Sciences published findings of the link between genital use of talcum powder and increased ovarian cancer risk at a molecular level. One of the major issues with the research is whether or not the association is "statistically significant" enough. Johnson & Johnson can try to poke holes in the data, but we believe the facts speak for themselves. Why We Need Your Help According to the Center for Disease Control and Prevention, about 20,000 U.S. women are diagnosed with ovarian cancer each year. An estimated 14,000 of them will die from it. Researchers estimate that talcum powder could be the cause of about 10 percent of ovarian cancer cases in the United States. This issue may also potentially impact childrens' health as asbestos has been found in talc-based cosmetics sold at Claire's and Justice as recently as 2017. Unfortunately, gaining federal regulation on talcum powder is no simple task. Since talcum products are classified as cosmetics, they technically aren’t subject to FDA review. The FDA allows the manufacturer to test their products before introducing them to market, making it the manufacturer’s responsibility to properly warn consumers and label products as safe for use. Despite this obstacle, juries have awarded plaintiffs significant settlements in recent years. In July 2018, a group of women was awarded $4.7 billion after being diagnosed with ovarian cancer as a consequence of the asbestos in Johnson & Johnson's baby powder and other talc products. These legislative victories have generated attention surrounding the risks of talc products, but resolution of the issue will require widespread effort to yield increased transparency from Johnson & Johnson. We fight for adequate warning labels so that consumers may be aware of the health risks they’re exposed to when using Johnson & Johnson’s talcum powder products. Let the consumer decide.  *Editor’s note: Johnson & Johnson’s Baby Powder product has also been linked to a rare and aggressive cancer called mesothelioma, caused by asbestos contamination. Make Your Voice Heard  Take a stand for all the victims and their loved ones who have been diagnosed with ovarian cancer caused by the use of talcum powder. Please join us in demanding that Johnson & Johnson add warning labels to their talcum powder products.   

3,079 supporters
Update posted 14 hours ago

Petition to Dräger , Ventilator manufacturers

Remove barriers to fixing ventilators

We are confronting a hard reality: U.S. hospitals do not have enough ventilators to meet the spike in respiratory failure that the novel coronavirus is projected to create. As ventilators are pressed into round-the-clock use, repair and maintenance issues will increase. While some ventilator manufacturers provide the service information that biomedical technicians need, other manufacturers make it hard to access manuals, read error logs or run diagnostic tests. We need to remove those barriers now. Add your name: Manufacturers must release the service information hospitals need to fix and maintain our vitally important ventilators. Hospitals in the United States don’t possess enough ventilators to meet the demand that COVID-19 is expected to create -- a reality that could have dire consequences for patients who will need these devices to breathe. As global demand for ventilators spikes, as manufacturers face heavy backlogs, and as factories are compelled to stop selling internationally, it will be nearly impossible to get enough ventilators into U.S. hospitals in time to meet the onslaught of critical cases. We’ll need to press older models into service that hospitals keep in store for emergency purposes. There are nearly 100,000 older ventilators around the United States -- but some will need repairs and maintenance, and that will require access to service information. Join us in calling on manufacturers to release the vital service information hospitals need to service and maintain all viable ventilators in the United States. Medical device manufacturers and trade associations actively lobby against Right to Repair reforms, which would mandate access to repair information and service software. While some manufacturers provide access to what technicians need, others do not provide full access to service information for their ventilators. On one independent online repository for ventilator service information, the message "Download prohibited by Dräger. Support is not desired" appears next to the deactivated links to service manuals, instructions and technical documentation for Dräger ventilators. Qualified repair technicians need access to manuals and other critical information to keep hospitals’ emergency ventilators up and running. Manufacturers claim that repairs done by independent technicians are not as safe or reliable as those done by the manufacturers’ technicians. The data says otherwise. An extensive 2018 study conducted by the Food and Drug Administration investigating repair and maintenance issues found that independent technicians, hospital technicians and manufacturers all “provide high quality, safe and effective servicing of medical devices.” Qualified hospital and independent technicians must have access to the proper information during this public health crisis. Tell ventilator manufacturers to free up service information, including repair manuals. Thank you, U.S. PIRG  1. Sarah Kliff, Adam Satariano, Jessica Silver-Greenberg and Nicholas Kulish, “There Aren’t Enough Ventilators to Cope With the Coronavirus,” New York Times, March 18, 2020. 2. Jason Koebler, “Hospitals Need to Repair Ventilators. Manufacturers Are Making That Impossible,” Vice, March 18, 2020.  3. Sarah Kliff, Adam Satariano, Jessica Silver-Greenberg and Nicholas Kulish, “There Aren’t Enough Ventilators to Cope With the Coronavirus,” New York Times, March 18, 2020.  4.  Sarah Kliff, Adam Satariano, Jessica Silver-Greenberg and Nicholas Kulish, “There Aren’t Enough Ventilators to Cope With the Coronavirus,” New York Times, March 18, 2020.  5. “United States Resource Availability for COVID-19,” Society of Critical Care Medicine, revised March 19, 2020.  6. “United States Resource Availability for COVID-19,” Society of Critical Care Medicine, revised March 19, 2020.  7. Jonathan Cohn, “How To Get More Ventilators And What To Do If We Can’t,” Huffpost, March 17, 2020.  8. “State Affairs -- 2018,” Advanced Medical Technology Association, accessed March 20, 2020.    9. Jason Koebler, “Hospitals Need to Repair Ventilators. Manufacturers Are Making That Impossible,” Vice, March 18, 2020.  10. “Ventilators Service Manuals,” Frank’s Hospital Workshop, accessed March 20, 2020.   11. Jason Koebler, “Hospitals Need to Repair Ventilators. Manufacturers Are Making That Impossible,” Vice, March 18, 2020.  12. “FDA Report on the Quality, Safety, and Effectiveness of Servicing of Medical Devices,” U.S. Food and Drug Administration, May 2018.

40,559 supporters
Update posted 2 days ago

Petition to Donald J. Trump, Donald J. Trump, Jeff Flake, John McCain, Donald Trump, Tulsi Gabbard, Raúl Grijalva, Beto O'Rourke, Mike Coffman, Earl Blumenauer, Walter B. Jones, Lindsey Graham, Dave Joyce, Carlos Curbelo, Ryan Costello, John Rutherford, Ruben Gallego, Tom O'Halleran, Kyrsten Sinema, Andy Biggs, Paul A. Gosar

Fight For Those Who Fought For You

A Call to Reason As Veterans of the United States Armed Forces we call on the Veterans Health Administration (V.H.A.) to fully recognize cannabis as a viable treatment option, which is a far less toxic alternative to commonly prescribed pharmaceuticals. Leaders are increasingly aware of the devastation to former military members (and their families) caused by inappropriate prescription of opiates, SSRIs, Benzodiazepines, and other pharmaceuticals. In 2011 the V.H.A. established internal policy officially outlining their position on cannabis, allowing physicians in “legal” states to discuss its use with their patients, at their own discretion. Multiple attempts have been made to resolve the inability of veterans to incorporate cannabis into their official treatment plans. Each and every one of these attempts have been sabotaged. The V.H.A. needs to take action on this issue. Federal leadership in the Executive and Legislative branches of our government need to understand the enormity of this pharmaceutical impact and available remedy. The fact is, veterans are self-medicating with cannabis. Most turn to cannabis after pharmaceutical options, some of which include warnings of suicidal ideation, fail. This situation is untenable. Because the V.H.A. is a federal program, operating in all fifty states, veterans are federal patients and require equal medical treatment/access to cannabis, regardless of state laws. Accordingly, an expansion of existing V.H.A. policy which would meet our needs is in order. The status quo is medically unethical. We request and require: Unobstructed ability to engage in open and honest dialogue with our V.H.A. Primary Care Teams about our use of cannabis, where we can then develop proper treatment plans, documenting our experiences. The ability to participate in research programs conducted by V.H.A., which would further assist us in our understanding of medical cannabis, and how to best introduce it into our treatment regimen. The ability to receive recommendations for cannabis from our V.H.A. Doctors, should that be the agreed upon treatment plan. Prescriptions from the V.H.A. filled at local dispensaries, or where dispensaries are not located/permitted, getting those scripts filled at the V.H.A. Pharmacy. A cannabis farm at every major V.H.A. healthcare facility designed to teach veterans about their medication, how to grow it, and to supply the hospital Pharmacy. This discussion, this reform, is long overdue. Join us.      

1620 Legion
150,394 supporters